Clin Pediatr Hematol Oncol.  2007 Oct;14(2):198-201.

A Case of Intractable Gastrointestinal Bleeding during Chemotherapy in Hereditary Coagulation Factor Deficiency

Affiliations
  • 1Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea. hwaph@chonbuk.ac.kr

Abstract

A congenital factor VII deficiency is a rare bleeding disorder and autosomal recessively inherited. Its clinical manifestations are variable from asymptomatic to life threatening bleeding. Chemotherapy can cause a hemorrhagic event due to tissue (mucosa) damage, multiple coagulation factor deficiency and thrombocytopenia. So the patient who has a cancer with congenital factor VII deficiency has a higher risk of bleeding during chemotherapy. We report a congenital factor VII deficient 11-year-old boy who was diagnosed as Ewing sarcoma and treated with multiple chemotherapeutic agents. The patient died of the chemotherapy 46 days due to intractable gastrointestinal bleeding despite the use of recombinant activated factor VII replacement and transfusion of fresh frozen plasma and platelet concentrates.

Keyword

Congenital factor VII deficiency; Gastrointestinal bleeding; Chemotherapy; Recombinant activated factor VII

MeSH Terms

Blood Coagulation Factors*
Blood Platelets
Child
Drug Therapy*
Factor VII
Factor VII Deficiency
Factor VIIa
Hemorrhage*
Humans
Male
Plasma
Sarcoma, Ewing
Thrombocytopenia
Blood Coagulation Factors
Factor VII
Factor VIIa
Full Text Links
  • CPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr